Plavsic Mark bought AURA
March 2, 2026 · Form 4 insider transaction
Plavsic Mark bought 62,339 shares of Aura Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
62,339
Price
$0.00
Total value
N/A
InsiderPlavsic Mark
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after243,736
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.